Top Midday Gainers

MT Newswires Live

Jul 15, 2025

Zimmer Biomet (ZBH) signed a definitive agreement to acquire Monogram Technologies (MGRM) for a cash payment of $4.04 per common share, for a total equity value of about $177 million, the companies said Monday.

Shares of Monogram soared 76% as intraday trading volume catapulted to over 13.4 million from a daily average of about 60,000.

Dare Bioscience (DARE) said Monday that interim results from its phase 3 clinical trial showed that its investigational monthly, hormone-free intravaginal contraceptive, Ovaprene, met the company's expectations.

Shares surged 66% as intraday trading volume climbed to more than 63.8 million from a daily average of about 163,000.

Sonnet BioTherapeutics (SONN) shares soared 72% amid heavy trading after the company said it agreed to merge with Rorschach, backed by Atlas Merchant Capital and Paradigm Operations, and will build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain.

More than 40.2 million shares of Sonnet traded intraday compared with a daily average of about 2.91 million.

Price: 93.61, Change: -0.19, Percent Change: -0.20

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2551382751"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551382751\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551382751?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-15 01:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551382751","market":"fut","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/ZBH\">Zimmer Biomet</a> (ZBH) signed a definitive agreement to acquire Monogram Technologies (MGRM) for a cash payment of $4.04 per common share, for a total equity value of about $177 million, the companies said Monday.</p><p>Shares of Monogram soared 76% as intraday trading volume catapulted to over 13.4 million from a daily average of about 60,000.</p><p><a href=\"https://laohu8.com/S/DARE\">Dare Bioscience</a> (DARE) said Monday that interim results from its phase 3 clinical trial showed that its investigational monthly, hormone-free intravaginal contraceptive, Ovaprene, met the company's expectations.</p><p>Shares surged 66% as intraday trading volume climbed to more than 63.8 million from a daily average of about 163,000.</p><p>Sonnet BioTherapeutics (SONN) shares soared 72% amid heavy trading after the company said it agreed to merge with Rorschach, backed by <a href=\"https://laohu8.com/S/AFH\">Atlas</a> Merchant Capital and Paradigm Operations, and will build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain.</p><p>More than 40.2 million shares of Sonnet traded intraday compared with a daily average of about 2.91 million.</p><p>Price: 93.61, Change: -0.19, Percent Change: -0.20</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-15 01:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/ZBH\">Zimmer Biomet</a> (ZBH) signed a definitive agreement to acquire Monogram Technologies (MGRM) for a cash payment of $4.04 per common share, for a total equity value of about $177 million, the companies said Monday.</p><p>Shares of Monogram soared 76% as intraday trading volume catapulted to over 13.4 million from a daily average of about 60,000.</p><p><a href=\"https://laohu8.com/S/DARE\">Dare Bioscience</a> (DARE) said Monday that interim results from its phase 3 clinical trial showed that its investigational monthly, hormone-free intravaginal contraceptive, Ovaprene, met the company's expectations.</p><p>Shares surged 66% as intraday trading volume climbed to more than 63.8 million from a daily average of about 163,000.</p><p>Sonnet BioTherapeutics (SONN) shares soared 72% amid heavy trading after the company said it agreed to merge with Rorschach, backed by <a href=\"https://laohu8.com/S/AFH\">Atlas</a> Merchant Capital and Paradigm Operations, and will build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain.</p><p>More than 40.2 million shares of Sonnet traded intraday compared with a daily average of about 2.91 million.</p><p>Price: 93.61, Change: -0.19, Percent Change: -0.20</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2551382751","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551382751","pubTimestamp":1752515782,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Zimmer Biomet (ZBH) signed a definitive agreement to acquire Monogram Technologies (MGRM) for a cash payment of $4.04 per common share, for a total equity value of about $177 million, the companies sa","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","SONN":"Sonnet BioTherapeutics Holdings, Inc.","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","BK4566":"资本集团","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","ZBH":"齐默巴奥米特控股","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","BK4584":"避孕概念","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","BK4585":"ETF&股票定投概念","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","BK4139":"生物科技","DARE":"Dare Bioscience","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","MGRM":"Monogram Orthopaedics Inc","BK4082":"医疗保健设备","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4504":"桥水持仓","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","BK4588":"碎股","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DARE":0.9,"SONN":0.9,"ZBH":0.9,"MGRM":0.9},"content_text":"Zimmer Biomet (ZBH) signed a definitive agreement to acquire Monogram Technologies (MGRM) for a cash payment of $4.04 per common share, for a total equity value of about $177 million, the companies said Monday.Shares of Monogram soared 76% as intraday trading volume catapulted to over 13.4 million from a daily average of about 60,000.Dare Bioscience (DARE) said Monday that interim results from its phase 3 clinical trial showed that its investigational monthly, hormone-free intravaginal contraceptive, Ovaprene, met the company's expectations.Shares surged 66% as intraday trading volume climbed to more than 63.8 million from a daily average of about 163,000.Sonnet BioTherapeutics (SONN) shares soared 72% amid heavy trading after the company said it agreed to merge with Rorschach, backed by Atlas Merchant Capital and Paradigm Operations, and will build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain.More than 40.2 million shares of Sonnet traded intraday compared with a daily average of about 2.91 million.Price: 93.61, Change: -0.19, Percent Change: -0.20","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}